Panelist discuss individualized treatment strategies that balance efficacy, tolerability, and lifestyle considerations to move patients beyond maintenance plateaus in chronic inflammatory demyelinating polyneuropathy (CIDP) care.
Amit Sachdev, MD, MS
Advertisement
Articles by Amit Sachdev, MD, MS
Panelist discuss how chronic inflammatory demyelinating polyneuropathy (CIDP) clinical trials have progressed toward patient-focused designs that strengthen scientific rigor while safeguarding participants.
Panelist discuss the clinical reasoning, electrophysiologic tools, and consensus criteria that underpin accurate diagnosis and differentiation of chronic inflammatory demyelinating polyneuropathy (CIDP) from other neuropathies.
Advertisement
Latest Updated Articles
Ensuring a Comprehensive Diagnosis of CIDP and the Role of EMGPublished: November 6th 2025 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Repositioning GLP-1 Drugs for Neurologic Disease: Evidence, Advances, and Outlook
2
CAPN2-Targeting Agent AMX0114 Shows Safe Profile in Phase 1 LUMINA Trial of ALS
3
What the First Intrathecal Gene Therapy Means for SMA Clinicians and Researchers
4
FDA Approves Inebilizumab for Myasthenia Gravis, Phase 3 PREVAiLS Study Launched, Tolebrutinib Fails Phase 3 PERSEUS Study
5